| Literature DB >> 24574595 |
Sumitha Mary Jacob1, Tony Thomson Chandy2, Verghese T Cherian3.
Abstract
BACKGROUND: The success of functional endoscopic sinus surgery (FESS) depends on visual clarity of the surgical field, through the endoscope. The objective of this double-blind, randomized, controlled study was to determine if a pre-operative dose of bisoprolol (2.5 mg) would reduce the bleeding during FESS and improve the visualization of the operative field.Entities:
Keywords: Beta-blocker; bisoprolol; blood loss; functional endoscopic sinus surgery; surgical field
Year: 2014 PMID: 24574595 PMCID: PMC3927294 DOI: 10.4103/0970-9185.125705
Source DB: PubMed Journal: J Anaesthesiol Clin Pharmacol ISSN: 0970-9185
The demographic data were comparable between the two groups
The estimated blood loss was significantly more in the control group. The decrease in hemoglobin was also significantly more in the control group
The operative field was graded by the surgeon, according to Fromme-Boezaart grading scale and it was found to be more favorable in those who received bisoprolol
Figure 1The average heart rate was significantly lower in the “bisoprolol” group compared to the “control” group
Figure 2The mean arterial pressure (MAP) tended to be higher in the “control” group despite efforts to maintain it between 60 and 70 mmHg. The average MAP in the “control” and the “bisoprolol” group, during the actual surgery time, was 70 ± 2.7 and 62 ± 3.6 mmHg respectively
The anesthetic requirement was significantly reduced in the “bisoprolol” group